CRISPR-Cas12a-based ultrasensitive assay for visual detection of SARS-CoV-2 RNA
The Analyst · 2024
DOI: 10.1039/d4an00479e ↗Kurz gefasst
Fachartikel in der Zeitschrift The Analyst, 2024. Verfasst von Shaohua Gong und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative I…. Hauptthemen laut MEDLINE: SARS-CoV-2, CRISPR-Cas Systems, RNA, Viral, Limit of Detection. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
We have integrated recombinase polymerase amplification (RPA) with the CRISPR-Cas12a system to design an ultrasensitive strategy for visual nucleic acid testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Univ…
- Laoshan Laboratory, Qingdao 266237, P. R. China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gong, S., Song, K., Pan, W., Li, N., & Tang, B. (2024). CRISPR-Cas12a-based ultrasensitive assay for visual detection of SARS-CoV-2 RNA. The Analyst. https://doi.org/10.1039/d4an00479e
Vancouver
Gong S, Song K, Pan W, Li N, Tang B. CRISPR-Cas12a-based ultrasensitive assay for visual detection of SARS-CoV-2 RNA. The Analyst. 2024. doi:10.1039/d4an00479e
BibTeX
@article{Gong2024,
author = {Gong, Shaohua and Song, Kexin and Pan, Wei and Li, Na and Tang, Bo},
title = {CRISPR-Cas12a-based ultrasensitive assay for visual detection of SARS-CoV-2 RNA},
journal = {The Analyst},
year = {2024},
doi = {10.1039/d4an00479e}
}
EUVIMED